Galkin Amends Innovative Eyewear Stake

TL;DR

Galkin updated his 13D for $BOSSY - check for ownership changes.

AI Summary

Vladimir Galkin has amended his Schedule 13D filing for Innovative Eyewear, Inc. on September 17, 2024. The filing indicates a change in beneficial ownership of the company's common stock. Galkin's address is listed as 10900 NW 97th Street, #102, Miami, FL 33178.

Why It Matters

This amendment signals a potential shift in control or significant shareholder interest in Innovative Eyewear, Inc., which could impact the stock price and future corporate actions.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant changes in beneficial ownership, which can lead to increased volatility and potential strategic shifts for the company.

Key Players & Entities

• Vladimir Galkin (person) — Filing person and beneficial owner
• Innovative Eyewear, Inc. (company) — Subject company
• 45791D109 (dollar_amount) — CUSIP Number for Common Stock

FAQ

Key Financial Figures

• $0.00001 — me of Issuer) Common Stock, par value $0.00001 per share (Title of Class of Securiti
• $4,961,164 — ted herein. A total of approximately i) $4,961,164 was paid by the Reporting Persons to ac
• $2,540,174 — 785,144 shares of Common Stock; and ii) $2,540,174 was received by the Reporting Persons a

Filing Documents

• vg_sc13dz.htm (SC 13D/A) — 69KB
• 0001376474-24-000517.txt ( ) — 70KB

Security and Issuer

ITEM 1. Security and Issuer This statement on Schedule 13D (this " Schedule 13D") originally filed with the Securities and Exchange Commission (the " SEC") on September 23, 2024, jointly by (i) Vladimir Galkin and Angelica Galkin, husband and wife, each a citizen of the United States of America; and ii) The Angelica Galkin Revocable Trust, dated April 21, 2018 ("Galkin Revocable Trust") (collectively, the "Reporting Persons" and individually, a "Reporting Person"), with respect to the shares of the common stock, par value $0.00001 per share (the " Common Stock"), of Innovative Eyewear, Inc., a Florida corporation (the " Issuer"), is hereby amended to furnish the additional information set forth herein. All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in Schedule 13D.

Source and Amount of Funds or Other Consideration

ITEM 3. Source and Amount of Funds or Other Consideration . The Galkin Revocable Trust used personal funds and margin account borrowings made in the ordinary course of business to make the purchases of shares of Common Stock listed herein. The positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the shares of Common Stock reported herein. A total of approximately i) $4,961,164 was paid by the Reporting Persons to acquire 785,144 shares of Common Stock; and ii) $2,540,174 was received by the Reporting Persons as payment for the sale of 365,144 shares of Common Stock reported herein. Part of the purchase price to acquire such shares of Common Stock was obtained through margin borrowing.

Interest in Securities of the Issuer

ITEM 5. Interest in Securities of the Issuer . (a) As of the date hereof, each of Vladimir Galkin, Angelica Galkin, and the Galkin Revocable Trust may be deemed to beneficially own 420,000 shares of Common Stock held by the Galkin Revocable Trust, representing approximately 26.7% of the outstanding shares of Common Stock of Issuer. The foregoing beneficial ownership percentages reported in this Item 5 are based upon 1,570,569 shares of the Issuer's Common Stock outstanding as of August 12, 2024, as reported in the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024, and filed by the Issuer with the Securities and Exchange Commission (the "SEC") on August 12, 2024. (b) See Rows 7-10 of the cover page for information regarding the power to vote or direct the vote and the power to dispose or direct the disposition of the shares of Common Stock by each of the Reporting Persons. (c) All the transactions involving shares of Common Stock effected during the past sixty (60) days by any of the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference. Except as otherwise noted below, all such transactions were purchases and sales of shares of Common Stock effected in the open market, and the table includes commissions paid in per share prices. (d) Not applicable. (e) No person other than a Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, Common Stock beneficially owned by the Reporting Persons.

Material to Be Filed as Exhibits

ITEM 7. Material to Be Filed as Exhibits . 1. Exhibit A - Joint Filing Agreement of the Reporting Persons. 13D CUSIP No. 45791D109 Page 6 of 7 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: September 23, 2024 By: /s/ Vladimir Galkin Vladimir Galkin Date: September 23, 2024 By: /s/ Angelica Galkin Angelica Galkin ANGELICA GALKIN REVOCABLE TRUST Date: September 23, 2024 /s/ Angelica Galkin By: Angelica Galkin Title: Trustee 13D CUSIP No. 45791D109 Page 7 of 7 Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Stock of the Issuer which were effectuated by Reporting Persons during the past sixty (60) days. All transactions were effectuated in the open market through a broker. Name of Reporting Person Date of Transactions Type of Transactions Number of Securities Price Per Share (1) Galkin Revocable Trust 09/16/24 Purchase 438,408 $ 5.68 Galkin Revocable Trust 09/16/24 Sale (106,661) $ 6.19 Galkin Revocable Trust 09/17/24 Purchase 346,736 $ 7.12 Galkin Revocable Trust 09/17/24 Sale (258,483) $ 7.27 (1) The prices reported are weighted-average prices and include commissions paid in per share prices. These shares of Common Stock were purchased in multiple transactions. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in this Footnote 1. 13D Exhibit A JOINT FILING AGREEMENT This Joint Filing Agreement (this "Agreement") hereby confirms the agreement by and among all of the undersigned that the Schedule 13D to which this Agreement is attached as Exhibit A, with respect to the beneficial ownership of the undersigned shares of

View Full Filing

View this SC 13D/A filing on SEC EDGAR